EN
HI
Kabra Drugs Share price
KABRADG
21.33
1.01 (4.97%)Last updated on 17 Jul, 2025 | 12:01 IST
BUYSELL
Today's High
21.33
Today's Low
21.33
52 Week Low
8.30
52 Week High
22.77
The current prices are delayed, login to your account for live prices
LoginKabra Drugs Chart
Kabra Drugs Share Key Metrics
Volume
19509.00
Market Cap
48.17 CR
LTQ@LTP
851@21.33
ATP
21.33
Var Margin
100 %
Circuit Range
19.31-21.33
Delivery %
0 %
Value
4.16 L
ASM/GSM
No
Market Lot
1
Kabra Drugs Corporate Actions
Kabra Drugs News
About Kabra Drugs
NSE : 0
BSE : 524322
ISIN : INE323K01017
Kabra Drugs Management
| Name | Position |
|---|---|
| Mr. N Aravind | Managing Director |
| Mr. Bangalore Venkatakrishnappa Ananth Kumar | WholeTime Director & CFO |
| Mr. Kuniamuthur Nanjappan Anand | Executive Director |
| Mrs. A Anitha | Independent Director |
| Mrs. Ananthkumar Shilpa | Independent Woman Director |
Kabra Drugs Similar Stocks
Decipher Labs Ltd.
11.80
0.05 (0.43%)
Hindustan Bio Sciences Ltd.
9.00
-0.31 (3.33%)
Cian Healthcare Ltd.
3.84
-0.06 (1.54%)
Ortin Global Ltd.
11.70
0.08 (0.69%)
Dhanvantri Jeevan Rekha Ltd.
20.05
0.05 (0.25%)
Dr Lalchandani Labs Ltd.
NaN
-20.58 (2058.00%)
Transpact Enterprises Ltd.
NaN
-277.70 (27770.00%)
MPS Pharmaa Ltd.
2.72
2.72 (272.00%)
Kobo Biotech Ltd.
2.65
0.12 (4.74%)
Kabra Drugs FAQs
The Buying Price of Kabra Drugs share is 21.33 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Kabra Drugs share log in to your Choice trading account, or open a Choice Demat account, then add funds, search the company name, select your order type, and place your trade.
The Price-to-earnings (P/E) ratio of Kabra Drugs shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Kabra Drugs shares is 0. Useful to assess the stock's value relative to its book value.
To assess Kabra Drugs’s valuation compare Sector P/E, P/B which are 35.16 & 4.18 with sector averages, along with growth rates and financial metrics.
The Market Cap of Kabra Drugs is 48.17 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Kabra Drugs share price is 22.77 & 8.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.